Replies to post #282 on The Moon Phase

[PoemStone]

BPOP. Declares Dividends on Preferred Stock, Announces Distribution on Trust Preferred Securities
http://ih.advfn.com/p.php?pid=nmona&article=54422071

[PoemStone]

StocksDiva Bio-Bin. FDA Target dates to Oct 29th. and chart links.
http://investorshub.advfn.com/StocksDiva-Bio-Bin-16112/

10/29/2012
Cornerstone Therapeutics Inc. CRTX
CRTX 080 (NDA)
FDA decision on CRTX 080 for treatment of hyponatremia
http://stockcharts.com/h-sc/ui?s=CRTX&p=W&yr=0&mn=10&dy=0&id=p98537415266

10/27/2012
United Therapeutics Corp UTHR
UT-15C Treprostinil Diethanolamine Sustained Release Tablets (NDA)
FDA decision on Treprostinil for pulmonary arterial hypertension
http://stockcharts.com/h-sc/ui?s=UTHR&p=W&yr=0&mn=10&dy=0&id=p19857067596

10/23/2012
Hyperion Therapeutics, Inc. HPTX
Ravicti (NDA)
FDA decision on Ravicti for treatment of urea cycle disorder
http://stockcharts.com/h-sc/ui?s=HPTX&p=W&yr=0&mn=10&dy=0&id=p43085630433

10/21/2012
Impax Laboratories Inc IPXL
IPX066 (NDA)
FDA decision on IPX066 for treatment of idiopathic Parkinson's disease
http://stockcharts.com/h-sc/ui?s=IPXL&p=W&yr=0&mn=10&dy=0&id=p69460166375

10/19/2012
Supernus Pharmaceuticals, Inc. SUPN
SPN-804 (NDA)
FDA decision on SPN-804 for epilepsy
http://stockcharts.com/h-sc/ui?s=SUPN&p=W&yr=0&mn=10&dy=0&id=p70809143664

10/16/2012
Santarus Inc. SNTS
UCERIS (NDA)
FDA decision on UCERIS for induction of remission of mild to moderate active ulcerative colitis
http://stockcharts.com/h-sc/ui?s=SNTS&p=W&yr=0&mn=10&dy=0&id=p15528194029